Multiple myeloma

What is new in Multiple myeloma research, which clinical trials are open, and who works on it. From public registries and PubMed, with the source and date of every fact.

Cure: Treatable, not yet curableSource: ESMO
Standard treatment: Combination drugs, often with stem cell transplantSource: ESMO

Cure status

Closest to patients

Lenalidomide and Dexamethasone With or Without Thalidomide in Treating Patients With Multiple MyelomaLenalidomide and Dexamethasone With or Without Thalidomide in Treating Patients With Multiple MyelomaSwedish American Hospital · Rockford, United States + 137 more hospitalsPhase 3Primary completion 2008
Lenalidomide in Treating Patients With Multiple Myeloma Undergoing Autologous Stem Cell TransplantLenalidomide in Treating Patients With Multiple Myeloma Undergoing Autologous Stem Cell TransplantPrisma Health Cancer Institute - Eastside · Greenville, United States + 139 more hospitalsPhase 3Primary completion 2012
Melphalan, Prednisone, and Thalidomide or Lenalidomide in Treating Patients With Newly Diagnosed Multiple MyelomaMelphalan, Prednisone, and Thalidomide or Lenalidomide in Treating Patients With Newly Diagnosed Multiple MyelomaSaint Mary Corwin Medical Center · Pueblo, United States + 390 more hospitalsPhase 3Primary completion 2014

Let us optimize your content

Apply for experimental treatment or a research study

The trial team decides who can take part; your doctor can help you ask.

Distance is calculated in your browser. Your city is not sent to us.

Loading trial sites…

See all 779 studies

Latest news

Results, new trials and publications, newest first. Every item links to its source.

Results and new studies, newest first, in plain words.

Plain-language summary pending. Original title shown.

15 Nov 2026
Review
Bispecific antibodies targeting B-cell maturation antigen in multiple myeloma: Current clinical applications, challenges and future directions.
Bispecific antibodies targeting B-cell maturation antigen in multiple myeloma: Current clinical applications, challenges and future directions.
Cancer
PubMed · PMID 42980050
4 Nov 2026
Publication
A turbidimetric alternative for analysis of total light chains in urine.
A turbidimetric alternative for analysis of total light chains in urine.
Scandinavian journal of clinical and laboratory investigation
PubMed · PMID 42980379
4 Nov 2026
Publication
Integration of peripheral blood lymphocyte subsets and cytokines enhances prognostic stratification in newly diagnosed multiple myeloma.
Integration of peripheral blood lymphocyte subsets and cytokines enhances prognostic stratification in newly diagnosed multiple myeloma.
British journal of haematology
PubMed · PMID 42979970
23 Oct 2026
Publication
The Effectiveness of Teclistamab in Patients With Relapsed/Refractory Light Chain Amyloidosis: A Multicenter Retrospective Study.
The Effectiveness of Teclistamab in Patients With Relapsed/Refractory Light Chain Amyloidosis: A Multicenter Retrospective Study.
British journal of hospital medicine (London, England : 2005)
PubMed · PMID 42980103
20 Oct 2026
Review
Engineering ex vivo T-cell expansion for CAR-T therapy: bridging biological fidelity and bioprocess scalability through platforms, functional consumables, and integrated closed manufacturing.
Engineering ex vivo T-cell expansion for CAR-T therapy: bridging biological fidelity and bioprocess scalability through platforms, functional consumables, and integrated closed manufacturing.
Frontiers in immunology
PubMed · PMID 42978867
1 Jul 2026
Case report
Intrathyroidal Relapse of Multiple Myeloma Mimicking Primary Thyroid Neoplasia: A Case Report and Literature Review.
Intrathyroidal Relapse of Multiple Myeloma Mimicking Primary Thyroid Neoplasia: A Case Report and Literature Review.
AACE endocrinology and diabetes
PubMed · PMID 42978806

See all 4312 news items

Organisations that can help

Helplines, patient groups and support services for you and your family.

International & European

International Myeloma Foundation (IMF)
Global myeloma charity: InfoLine (US/Canada toll-free and worldwide number, bookable calls), support group directory, Spanish-language groups, foreign-language resources incl. Hungarian and Polish pages.
International
Phone: +1-818-487-7455 (worldwide); 800-452-2873 (US/Canada)
Visit site: International Myeloma Foundation (IMF)
European Cancer Patient Coalition (ECPC)
Umbrella of European cancer patient groups, with a patient toolbox and a legal network for cancer patients.
Europe
Visit site: European Cancer Patient Coalition (ECPC)
European Patients' Forum (EPF)
Umbrella of European patient organisations and national patient coalitions.
Europe
Visit site: European Patients' Forum (EPF)
EURORDIS – Rare Diseases Europe
Alliance of over 1,000 rare disease patient organisations, with a list of rare disease helplines by country.
Europe
Visit site: EURORDIS – Rare Diseases Europe
Global Myeloma Action Network (International Myeloma Foundation)
IMF-run global coalition of myeloma patient groups: annual summit, international bill of rights for myeloma patients, educational grants, resources in other languages, access advocacy.
International
Visit site: Global Myeloma Action Network (International Myeloma Foundation)
International Alliance of Patients' Organizations
Global alliance of patient organisations of all diseases, promoting patient-centred healthcare.
International
Visit site: International Alliance of Patients' Organizations
Myeloma Patients Europe (MPE)
European umbrella of myeloma patient groups, with a list of members by country.
Europe
Visit site: Myeloma Patients Europe (MPE)
Workgroup of European Cancer Patient Advocacy Networks
Network of pan-European cancer patient umbrella groups (including the blood cancer networks): joint advocacy, WECAN Academy training for patient advocates, patient experience data courses.
Europe
Visit site: Workgroup of European Cancer Patient Advocacy Networks

Your country

Frontlight is not affiliated with these organisations; we list them because they help.

Checked automatically every 90 days.